Type 1 autoimmune hepatitis in Turkish patients: Absence of association with HLA B8

Journal of Clinical Gastroenterology

Volumn 35, Issue 2, 2002, Pages 185-190

  Kosar, Yasemin ^a   Kacar, Sabite ^a   Sasmaz, Nurgul ^a   Oguz, Perihan ^a   Turhan, Nesrin ^a   Parlak, Erkan ^a   Heneghan, Michael A ^a   McFarlane, Ian G ^a  

^a Subay Koop   (Turkey)

Author keywords

Autoimmune hepatitis; HLA; Turkey

Indexed keywords

HLA B8 ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LABORATORY DIAGNOSIS; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TURKEY (REPUBLIC); ADOLESCENT; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; ALLELES; FEMALE; GENOTYPE; HEPATITIS, AUTOIMMUNE; HLA-B8 ANTIGEN; HUMAN; MALE; MIDDLE AGE; RETROSPECTIVE STUDIES; TURKEY; HUMANS; MIDDLE AGED;

EID: 0036020438     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200208000-00012     Document Type: Article

References (33)

1. Chairmen, International Working Party report: Terminology of chronic hepatitis
2. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis
3. Association of autoimmune hepatitis with JLA-Bw4 and DR4 in Japanese patients
4. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors
5. Present status of autoimmune hepatitis in Japan: Correlating the characteristics with international criteria in an area with a high rate of HCV infection
6. Immunogenetic studies of autoimmune hepatitis and primary sclerosing cholangitis
7. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis
8. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition
9. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?
10. Histological grading and staging of chronic hepatitis
11. Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional autoantibodies
12. Clinical features and prognostic indications of severe corticosteroid-treated cryptogenic chronic active hepatitis
13. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
14. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis
15. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis
16. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease
17. Segregation of pANCA antigenic recognition by Dnase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis and primary sclerosing cholangitis
18. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
19. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases
20. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis
21. HLA antigens in Turkish race with rheumatic heart disease
22. HLA frequencies in the Turkish population and in end-stage renal disease patients
23. Human lymphocyte antigens (HLA) and Graves' disease in Turkey
24. Significance of HLA DR4 in type 1 autoimmune hepatitis
25. Fast and slow methylators: Do racial differences influence risk of allograft rejection?
26. In vitro response to immunosuppressive agents in blacks
27. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
28. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
29. Ethnic differences in thiopurine methyltransferase pharmacogenetics: Evidence for allele specificity in Caucasian and Kenyan individuals
30. Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation
31. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis
32. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis
33. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis